Beijing Gene+ Technology is based in Beijing, China. It has raised $220M in total funding. Latest round: Series D.
Beijing Gene+ Technology is based in Beijing, China. Beijing Gene+ Technology has raised $220M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2025. The round record for Beijing Gene+ Technology runs through 2025; nothing later has been disclosed. Investors on record include Huagai Capital, WisdoMont Asset Management, Notable Capital, CCB International, AliHealth, Baidu Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Totals shown for Beijing Gene+ Technology aggregate every disclosed round on file. To see how that compares, browse the companies in Beijing and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026